APA

Chang C. H., McNamara L. A., Wu M. S., Muise E. S., Tan Y., Wood H. B., Meinke P. T., Thompson J. R., Doebber T. W., Berger J. P. & McCann M. E. (20080710). A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects. : European journal of pharmacology.

Chicago

Chang Ching H, McNamara Lesley A, Wu Margaret S, Muise Eric S, Tan Yejun, Wood Harold B, Meinke Peter T, Thompson John R, Doebber Tom W, Berger Joel P and McCann Margaret E. 20080710. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects. : European journal of pharmacology.

Harvard

Chang C. H., McNamara L. A., Wu M. S., Muise E. S., Tan Y., Wood H. B., Meinke P. T., Thompson J. R., Doebber T. W., Berger J. P. and McCann M. E. (20080710). A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects. : European journal of pharmacology.

MLA

Chang Ching H, McNamara Lesley A, Wu Margaret S, Muise Eric S, Tan Yejun, Wood Harold B, Meinke Peter T, Thompson John R, Doebber Tom W, Berger Joel P and McCann Margaret E. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects. : European journal of pharmacology. 20080710.